Abstract 1846P
Background
Confronting breast cancer diagnosis, alongside with complex and challenging treatment procedures comprise an extremely stressful experience. Psychological resilience (PR) is the ability to maintain or restore normal functioning while facing the adversity, leading to better quality of life and preventing stress-related health conditions in cancer patients. We aimed to investigate the impact of early breast cancer (EBC) diagnosis on PR, distress and perception of health.
Methods
Case-controlled study included 50 newly diagnosed EBC patients and 67 women without breast cancer whose screening mammography was graded by Breast imaging-reporting and data system 1 and 2. The level of distress, perception of health and PR were assessed using the Depression Anxiety and Stress Scale 21, SF 36-Item Health Survey 1.0 and Connor-Davidson RISC-25 scale. EBC patients were questioned after confronting EBC diagnosis and before starting the treatment.
Results
The EBC patients reported deterioration of health, compared to previous year (t (df) 3,835, p<0.01), while there were no differences between groups related to general and emotional health. There was no significant statistical difference between groups regarding the levels of depression, anxiety and stress. Majority of the EBC patients and controls, 66% and 82%, had no symptoms of depression, while severe depression was noted in 10% and 3%, respectively. Around 78% EBC patients and 89% controls didn't show any anxiety. Still, 8% EBC patients and 4.5% controls were severely anxious, and 10% EBC and 4% controls were severely stressed. And finally, regarding resilience, EBC patients showed significantly higher levels of PR than healthy control (t(df) 2,530, p<0.05).
Conclusions
Confronting EBC diagnosis, possibly leads to activation of intra-individual coping mechanisms and dynamic processes of effective adaptation leading to higher PR levels of EBC patients compared with healthy controls. Further research of PR should be encouraged, by investigating the mechanisms that protect individuals and prevent stress-related health conditions, resilience research shifts a paradigm from a disease-oriented to health-oriented and focuses on mechanisms that prevent stress-related disorders.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
1594P - End-of-life hospital cancer care in the COVID-19 era: A retrospective population-based study in the Netherlands
Presenter: Ellis Slotman
Session: Poster session 05
1595P - Incidence and characterization of end-of-life (EoL) systemic anticancer therapy (SACT) in melanoma patients (pts): A monocentric experience
Presenter: Silvia Buriolla
Session: Poster session 05
1596P - Exploring the economic impact of palliative care in oncology at the end of life
Presenter: Sarah Gomes
Session: Poster session 05
1597P - Improving in-hospital end-of-life care (EOLC) for oncology patients in a tertiary cancer centre
Presenter: Conor Moloney
Session: Poster session 05
1598P - Differences in referral patterns to the palliative care team among specialized physicians in patients with terminal cancer
Presenter: Hyun Jeong Shim
Session: Poster session 05
1599P - Clinical predictors of 30-day mortality in hospitalized patients with lung cancer: A retrospective single-center observational study
Presenter: Alessandro Leonetti
Session: Poster session 05
1600P - Sarcopenia, depression, and poor health perception among cancer patients registered in an oncology center in Pakistan
Presenter: Sobia Yaqub
Session: Poster session 05
1601P - Relationship between CT and ultrasonography-based sarcopenia and hematologic toxicity in patients with cancer receiving chemotherapy
Presenter: Gurkan Guner
Session: Poster session 05
1602P - Simulation training for compassionate extubation in the pediatric intensive care unit
Presenter: Nicole Fernandez
Session: Poster session 05
1603P - The ability of the LACE index to predict 30-day readmissions in oncology patients
Presenter: Burcu Ulas Kahya
Session: Poster session 05